Dr. Markian Bochan, MD

Infectious Disease Carmel, IN Male
NPI: 1972541936
Total Payments
$180,977
2024 Payments
$409.94
Companies
28
Transactions
361
Medicare Patients
3,162
Medicare Billing
$670,394

Payment Breakdown by Category

Other$123,666 (68.3%)
Travel$26,951 (14.9%)
Consulting$21,480 (11.9%)
Food & Beverage$8,880 (4.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $75,756 33 41.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $47,460 20 26.2%
Travel and Lodging $26,951 85 14.9%
Consulting Fee $21,480 8 11.9%
Food and Beverage $8,880 214 4.9%
Grant $450.00 1 0.2%

Top Paying Companies

Company Total Records Latest Year
The Medicines Company $63,750 90 $0 (2017)
Melinta Therapeutics, LLC $43,888 58 $0 (2020)
Merck Sharp & Dohme Corporation $30,493 75 $0 (2019)
TETRAPHASE PHARMACEUTICALS, INC. $19,069 19 $0 (2019)
La Jolla Pharmaceutical Company $11,411 18 $0 (2024)
Ferring Pharmaceuticals Inc. $7,680 3 $0 (2022)
Horizon Therapeutics plc $1,988 2 $0 (2020)
ABBVIE INC. $867.79 14 $0 (2024)
AngioDynamics, Inc. $244.26 3 $0 (2024)
T2 Biosystems, Inc. $237.72 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $409.94 6 La Jolla Pharmaceutical Company ($248.78)
2023 $5,175 6 La Jolla Pharmaceutical Company ($4,699)
2022 $9,486 8 Ferring Pharmaceuticals Inc. ($5,520)
2021 $2,210 6 La Jolla Pharmaceutical Company ($2,060)
2020 $4,282 5 Ferring Pharmaceuticals Inc. ($2,160)
2019 $32,535 68 TETRAPHASE PHARMACEUTICALS, INC. ($19,069)
2018 $42,425 99 Melinta Therapeutics, Inc. ($31,420)
2017 $84,454 163 The Medicines Company ($63,750)

All Payment Transactions

361 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
09/12/2024 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $121.37 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
09/11/2024 AngioDynamics, Inc. ANGIOVAC (Device) Food and Beverage In-kind items and services $105.77 General
Category: VIT
08/30/2024 AngioDynamics, Inc. ANGIOVAC (Device) Food and Beverage In-kind items and services $17.15 General
Category: VIT
02/20/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $18.12 General
Category: Respiratory
01/31/2024 La Jolla Pharmaceutical Company XACDURO (Drug) Food and Beverage In-kind items and services $127.41 General
Category: INFECTIOUS DISEASE
01/25/2024 ABBVIE INC. TEFLARO (Drug), AVYCAZ, DALVANCE Food and Beverage In-kind items and services $20.12 General
Category: ANTI-INFECTIVE
12/04/2023 AbbVie Inc. DALVANCE (Drug) Grant Cash or cash equivalent $450.00 General
Category: ANTI-INFECTIVE
10/10/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $26.68 General
Category: ANTI-INFECTIVE
04/18/2023 La Jolla Pharmaceutical Company XERAVA (Drug) Honoraria Cash or cash equivalent $2,242.00 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
04/05/2023 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $103.67 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
01/31/2023 La Jolla Pharmaceutical Company XERAVA (Drug) Honoraria Cash or cash equivalent $2,242.00 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
01/18/2023 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $110.94 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
11/30/2022 La Jolla Pharmaceutical Company XERAVA (Drug) Honoraria Cash or cash equivalent $1,875.00 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
11/15/2022 Ferring Pharmaceuticals Inc. — Consulting Fee Cash or cash equivalent $1,840.00 General
11/03/2022 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $78.26 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
11/03/2022 La Jolla Pharmaceutical Company XERAVA (Drug) Travel and Lodging In-kind items and services $26.11 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
05/02/2022 ABBVIE INC. — Food and Beverage In-kind items and services $21.06 General
04/20/2022 Ferring Pharmaceuticals Inc. — Consulting Fee Cash or cash equivalent $3,680.00 General
03/02/2022 La Jolla Pharmaceutical Company XERAVA (Drug) Honoraria Cash or cash equivalent $1,875.00 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
02/09/2022 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $90.12 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
10/05/2021 La Jolla Pharmaceutical Company XERAVA (Drug) Honoraria Cash or cash equivalent $1,875.00 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
09/08/2021 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $89.36 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
07/09/2021 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $15.43 General
Category: ANTI-INFECTIVE
06/29/2021 La Jolla Pharmaceutical Company XERAVA (Drug) Food and Beverage In-kind items and services $95.19 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
06/24/2021 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $13.58 General
Category: ANTI-INFECTIVE
123…15»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 698 1,677 $337,604 $139,535
2022 10 685 1,864 $399,615 $150,691
2021 9 755 1,985 $442,387 $167,450
2020 10 1,024 2,512 $559,401 $212,719
Total Patients
3,162
Total Services
8,038
Medicare Billing
$670,394
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 204 730 $145,755 $64,600 44.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 151 498 $69,682 $29,164 41.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 151 168 $53,760 $21,517 40.0%
99291 Critical care, first 30-74 minutes Facility 2023 28 50 $29,500 $8,110 27.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 23 35 $8,000 $4,486 56.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 40 42 $11,340 $3,934 34.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 38 46 $7,792 $3,645 46.8%
G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th Facility 2023 19 47 $3,525 $1,094 31.0%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 16 31 $3,255 $1,092 33.5%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 16 16 $3,360 $1,004 29.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 14 $1,635 $888.42 54.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 215 1,023 $204,320 $77,408 37.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 159 180 $57,600 $25,859 44.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 130 354 $49,560 $18,314 37.0%
99291 Critical care, first 30-74 minutes Facility 2022 34 100 $59,000 $15,875 26.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 35 57 $9,550 $4,653 48.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 15 28 $6,400 $3,721 58.1%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 31 31 $8,370 $3,182 38.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 17 20 $2,400 $1,033 43.0%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 16 23 $2,415 $644.96 26.7%
90611 Smallpox&monkeypox vac 0.5ml Office 2022 33 48 $0.48 $0.48 100.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 228 895 $178,755 $68,969 38.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 181 595 $83,300 $31,285 37.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 178 203 $64,960 $29,733 45.8%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 51 152 $89,680 $25,839 28.8%
12»

About Dr. Markian Bochan, MD

Dr. Markian Bochan, MD is a Infectious Disease healthcare provider based in Carmel, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972541936.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Markian Bochan, MD has received a total of $180,977 in payments from pharmaceutical and medical device companies, with $409.94 received in 2024. These payments were reported across 361 transactions from 28 companies. The most common payment nature is "Honoraria" ($75,756).

As a Medicare-enrolled provider, Bochan has provided services to 3,162 Medicare beneficiaries, totaling 8,038 services with total Medicare billing of $670,394. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Infectious Disease
  • Location Carmel, IN
  • Active Since 06/03/2006
  • Last Updated 06/15/2010
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1972541936

Products in Payments

  • ORBACTIV (Drug) $56,409
  • Vabomere (Drug) $25,584
  • ZINPLAVA (Biological) $19,439
  • Xerava (Drug) $19,069
  • XERAVA (Drug) $10,929
  • Orbactiv (Drug) $10,793
  • VABOMERE (Drug) $7,162
  • Baxdela (Drug) $4,530
  • DIFICID (Drug) $2,792
  • TEPEZZA (Drug) $1,920
  • DALVANCE (Drug) $535.04
  • GIAPREZA (Drug) $354.57
  • Mavyret (Drug) $301.87
  • ISENTRESS (Drug) $235.95
  • VIBATIV (Drug) $215.75
  • ZERBAXA (Drug) $173.01
  • Circulatory Support (Device) $135.78
  • XACDURO (Drug) $127.41
  • T2Dx (Device) $124.33
  • Symtuza (Drug) $122.94

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Carmel

Francisco Delgado, M.d, M.D

Infectious Disease — Payments: $55,789

Infectious Disease $55,789

Tracey Ikerd, Md, MD

Infectious Disease — Payments: $54,660

Infectious Disease $54,660

Chad Tewell

Infectious Disease — Payments: $2,160

Infectious Disease $2,160

Dr. Hassan Elmalik, Md, MD

Infectious Disease — Payments: $1,875

Infectious Disease $1,875

Dr. Joshua Berg, M.d, M.D

Infectious Disease — Payments: $1,401

Infectious Disease $1,401

Joseph Fraiz, Md, MD

Infectious Disease — Payments: $1,031

Infectious Disease $1,031